Just published: Value In Health theme section on assessing the value of clinical genomic testing

Around 12 months ago I joined an exciting new venture: the Population Genomics Health Economists Working Group. This group is made up of health economists and policy researchers from major institutions across the globe who have been at the forefront of the incorporation of genomics into clinical care. The group is chaired by Kathryn A. Phillips, PhD, Director of the Center for Translational and Policy Research on Personalized Medicine (TRANSPERS) at the University of California. You can find out more about the group members here.

The first key output from this working group has been published today: a themed section in the September issue of Value in Health which addresses the challenges and solutions for assessment of the value of clinical genomic testing.

While it’s critical to assess the value of NGS, there are many methodological challenges to doing so. This series of expert articles highlights not only these challenges, but also suggests innovative solutions to move the value assessment process forward for precision medicine. The five papers in this this theme section (listed below) incorporate a wide range of perspectives and topics and use both systematic reviews and case studies. All five papers focus on the overarching issue of proposing new methodologies to assess the value of NGS-based technologies in clinical care. The proposals included are not only intended for health economic researchers, but also for other stakeholders including health technology assessment organisations, payers, clinical researchers, and the biotechnology and pharmaceutical industries.

Further outputs from this working group are planned for the next 12-18 months, so keep your eyes peeled for news. Most of the working group members will be attending the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting in Barcelona in November 2018. Please do come and find us during this ISPOR meeting if you want to chat in person about our current and future plans.

Value in Health Theme Section Articles 

2 thoughts on “Just published: Value In Health theme section on assessing the value of clinical genomic testing

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s